Risk Factors | Page 13 | Alzheimer's Prevention Registry

You are here

Risk Factors

Mental and Social Activity Delays the Symptoms of Alzheimer’s

A new report shows more intellectual activity over lifetimes does not show lower levels of Alzheimer's progression as those who reported less cognitive stimulation. Groups were able to delay the appearance of symptoms, presumably because their stronger intellectual base compensated for the effects of the disease for a longer period of time.


Poor Sleep May Contribute to Alzheimer's Disease

New research suggests that a good night's sleep may play an important role in helping protect the brain against memory decline associated with Alzheimer's. The study found that higher amounts of beta-amyloid were linked with poor sleep. Participants with the highest levels of beta-amyloid and the poorest quality of sleep also performed worst on memory tests that the researchers gave volunteers before and after sleep.


$10 Million in New Funding Adds Innovative Dimensions to Alzheimer's Disease Prevention Trial

CHICAGO, May 29, 2015 – The Alzheimer's Association, GHR Foundation and Fidelity Biosciences Research Initiative today announced $10 million in new research funding to Banner Alzheimer's Institute (BAI), Phoenix, Arizona, to support a groundbreaking Alzheimer's disease prevention trial that will launch later this year.

Ask the Expert: Exercise and Brain Health

This month's expert is Marilyn Albert, PhD, Johns Hopkins University, Professor of Neurology and Director of the Division of Cognitive Neuroscience.

Dear Dr. Albert,

I'm a 50-something male and lately I'm having difficulty remembering things that used to be at the top of my head: when to pay bills, errands I need to run. My wife thinks it's just aging. She recommends that I get away from the office and exercise more regularly. How will a workout at the gym help my memory? Are there certain kinds of exercise I should focus on?


Studies Confirm Brain Plaque Can Help Predict Alzheimer’s

New studies, with articles in JAMA, support the central early role in Alzheimer's of beta amyloid. The findings also confirm that amyloid screening, by PET scan or cerebral spinal fluid test, can help identify people for clinical trials of drugs to prevent Alzheimer's.


Latin America Spearheads a Global Effort to Find an Effective Alzheimer’s Drug

Scientific American magazine shares the story of 26 extended families throughout the Colombian province of Antioquia who are at high risk for a rare genetic form of Alzheimer’s and how Banner Alzheimer's Institute has partnered with a neurologist in Colombia to form an innovative clinical trial in the search for treatment.

Read More »

Alzheimer's Warning Signs

Three experts weigh in on the signs to look for in friends and family members who potentially have Alzheimer's.

Read More »

A Simple 3-Part Test May Predict Alzheimer’s

Ronald Petersen, director of the Alzheimer's Disease Research Center at the Mayo Clinic, is developing a test to diagnose Alzheimer's.

Read More »